VivaGel® BV demonstrated statistically significant efficacy in two pivotal phase 3 trials
VivaGel® BV consistently resulted in reduced rates of BV recurrence by the primary efficacy endpoint and five secondary efficacy measures, and delayed time to first recurrence VivaGel® BV resulted in sustained benefits 3 months after cessation of treatment…
LBT’S Woundvue™ Prototype to be Used at Central Adelaide Health Network
Australian medical technology company LBT Innovations Limited (ASX:LBT) has entered a collaboration agreement with Central Adelaide Local Health Network (CALHN) Vascular and Endovascular Services, to use LBT’s novel WoundVue™ prototype device in the clinical trial, “Predicting outcomes in…
Handy SME Info: TGA SME Assist Hub
Therapeutic goods regulation and legislation can be challenging to navigate. The SME Assist hub is designed to help small and medium enterprises, and R&D groups developing new medicines and medical devices (including apps) understand their regulatory and legislative…
State of the Sector Medical Technologies and Pharmaceuticals 2017
Victoria has one of the world’s largest life science clusters composed of the medical technology (medtech), biotechnology (biotech) and pharmaceutical industries. It is home to a vibrant commercial sector, key R&D infrastructure and advanced manufacturing expertise making it…
Clinical Trials in Australia: the economic profile and competitive position of the sector
Clinical trials are an integral part of the research and development of new treatments, interventions or tests, and the refinement of existing standards of care and clinical practices. As such, they are vital to the future of healthcare.…
Bionic vision a step closer with the CSIRO’s new computing system
People with profound vision loss are one step closer to having their sight effectively restored, thanks to a new investment from Australia’s chief science body into a large-scale scientific computing system. The new Bracewell system, which is being used by Data61’s computer vision group that…
Announcing the Victorian Clinical Trials – Gateway Project!
Victorian Clinical Trials – Gateway is a new digital portal for accessing clinical trial partners in Victoria. St Vincents Hospital Melbourne and the Victorian Government’s Department of Economic Development, Jobs, Training and Resources (DEDJTR) are collaborating to create the Gateway…
Joint Statement on Skilled Migration Visa Changes
July 2017 Restoration on skilled visas welcomed across medical technology, biotechnology and pharmaceutical sector. The restoration of key occupations for the medical technology, research and pharmaceutical sector to the skilled migration visa list has been welcomed by six…
BioMelbourne Network Welcomes Revisions to Skilled Migration Visas
July 2017 Revisions to the skilled migration list have been welcomed by many BioMelbourne Network members across the biotechnology, medical technology and pharmaceutical sector. The restoration of occupations such as life scientist, biotechnologist, CEO/General Manager, and biochemist to…
LBT TO DISTRIBUTE APAS® IN AUSTRALIA & NZ
Australian medical technology company LBT Innovations Limited (ASX: LBT) has been appointed by joint venture company Clever Culture Systems AG (CCS) as the distributor for APAS® Independence in Australia and New Zealand. This will see LBT as the…
20th June – PharmaMedtech Stories – Join the Conversation!
FREE Seminar and Q&A Session The Department of Industry, Innovation and Science’s Entrepreneurs’ Programme is pleased to announce a panel seminar and Q and A session with key experts in the Biotech/Medtech/Pharma Sector. This event is open for…
Department of Immigration Roundtable Discussion (May 2017)
BioMelbourne Network CEO, Dr Krystal Evans attended a technology industries roundtable discussion with the Department of Immigration and the Department of Industry regarding skilled migration and the decision to abolish the 457 visa program. The medical technology, biotechnology and…
